Lilly cuts 250 jobs and invests €100m at French site

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Filipefrazao)
(Image: Getty/Filipefrazao)

Related tags: Eli lilly, France, Diabetes

Lilly France announced 250 positions will be cut from its Fegersheim site but will also invest €100m to update facilities over the coming years.

Local media reports revealed the decision was based on a ‘transformative project’ for the Fegersheim site, which produces injectable drugs and employs approximately 1,400 staff.

In a statement, the company said that external pressures on the pricing of products necessitate the reduction of production costs.

The €100m ($114m) investment will see the company focus on bringing in new technology, which will also require the recruitment of staff members with the necessary skills. The funding for the site update will be provided through to 2021.

As a result, the company revealed that 25 new recruits will be hired. However, 250 members of the current site team would have their positions terminated by the end of 2020.

The facility will focus on the manufacture of ‘connected medicine’ for diabetes.

The company has been looking externally to develop innovative means of treating diabetes, such as its licensing deal with Sigilon Therapeutics for its cell therapy treatment​.

Related topics: Processing, Delivery technologies

Related news

Related products

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more

Webinars